Celiprolol in hypertension
- PMID: 2903654
- DOI: 10.1016/0002-8703(88)90135-4
Celiprolol in hypertension
Abstract
Celiprolol is a third-generation, beta-adrenoceptor antagonist with ancillary pharmacologic properties that are potentially advantageous in the treatment of hypertension. Celiprolol provides 24-hour control of blood pressure and in formal clinical trials has been found superior to a placebo and of equal efficacy to other commonly used beta-blocking drugs. It has also been found to be equally as effective as enalapril in lowering the resting blood pressure and superior in controlling the increases in blood pressure and heart rate during exercise. Celiprolol is known to exert a beneficial effect on the atheroprotective components of the risk factors for coronary heart disease, such as cholesterol triglyceride, and fibrinogen. Therefore the primary attributes of beta-blockade are uniquely advanced by celiprolol's ancillary pharmacologic activities.
Similar articles
-
Daytime-selective antihypertensive activity of celiprolol.Angiology. 1999 Oct;50(10):797-803. doi: 10.1177/000331979905001003. Angiology. 1999. PMID: 10535718 Clinical Trial.
-
The central and peripheral hemodynamics of celiprolol.Am Heart J. 1988 Nov;116(5 Pt 2):1405-11. doi: 10.1016/0002-8703(88)90131-7. Am Heart J. 1988. PMID: 2903651 Review.
-
Celiprolol and verapamil in the treatment of essential hypertension.Am Heart J. 1988 Nov;116(5 Pt 2):1437-8. doi: 10.1016/0002-8703(88)90137-8. Am Heart J. 1988. PMID: 2903656 Clinical Trial. No abstract available.
-
Comparison of the antihypertensive effects of celiprolol and enalapril.J Int Med Res. 1988;16 Suppl 1:73A-79A. J Int Med Res. 1988. PMID: 2906019 Clinical Trial.
-
Celiprolol in angina pectoris.Am Heart J. 1988 Nov;116(5 Pt 2):1422-5. doi: 10.1016/0002-8703(88)90134-2. Am Heart J. 1988. PMID: 2903653 Review.
Cited by
-
Evaluation of celiprolol, a new cardioselective beta 1-adrenergic blocker with vasodilating properties, in the treatment of mild to moderate hypertension in the elderly.Cardiovasc Drugs Ther. 1991 Jan;4 Suppl 6:1291-5. doi: 10.1007/BF00114236. Cardiovasc Drugs Ther. 1991. PMID: 1672605 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical